Lupin Shares Gain 1% on Launching Cataract Surgery Pain Reduction Drug
Shares of Lupin were trading in the green and 1% higher on 10 January after the company announced the launch of a cataract surgery pain...
Tag : Lupin
Lupin Shares Hit 52-Week High on Receiving USFDA Approval
Shares of Lupin hit a 52-week high of Rs 1,345.75 on 28 December after the company received approval from the USFDA (US Food and Drug...
Lupin Acquired Portfolio of Drugs in Europe and Canada
Pharmaceutical major Lupin Ltd, on 22 December, announced that it has acquired a portfolio of established products in Europe and Canada for a total consideration...
Lupin Shares Gain 3% on Receiving Approval From USFDA for Gout and Diabetes Drugs
Shares of Lupin were trading in the green and 3% higher on 18 December after the company announced receiving approval from the USFDA (US Food...
Lupin Shares Surge After Receiving Back-to-back USFDA approvals
Shares of Lupin experienced a 3% surge during early trading on November 24, a day after it disclosed tentative approval from the United States Food...
Lupin Gets USFDA Tentative Approval for Diabetes Medication
Lupin, on 23 November, announced that it had received approval from the USFDA (United States Food and Drug Administration) for Canagliflozin Tablets, 100 mg and...
Lupin Shares Hit 52-Week High on Stellar Q2 Earnings
Lupin shares opened in the green and hit a 52-week high of Rs 1,238.45 on 9 November after the company announced its earnings for the...
Lupin Shares Hit 52-Week High on Receiving Tentative Approval From USFDA
Shares of Lupin hit a 52-week high of Rs 1.224.90 on 8 November after the company announced that it had received tentative approval from USFDA...
Lupin Shares Trade Higher as Mandideep Facility Gets USFDA Clean Chit
Shares of pharma major Lupin were trading in the green and 1% above on 1 November after the company announced that it had received the...
Lupin Shares Trade 2% Lower Despite Approval from USFDA for Generic Antifungal Drug
Shares of Pharma Major Lupin were trading 2% lower on 23 October despite the company receiving approval from USFDA (the United States Food and Drug...